Head and Neck Diseases by Alexandros G.Sfakianakis: Durvalumab (MEDI4736) With Cetuximab in Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Τρίτη 2 Οκτωβρίου 2018

Durvalumab (MEDI4736) With Cetuximab in Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Conditions: Recurrent Head and Neck Cancer; Head and Neck Cancer; Head and Neck Neoplasms; Metastatic Cancer
Interventions: Drug: Durvalumab; Drug: Cetuximab
Sponsors: Trisha Wise-Draper; AstraZeneca
Recruiting

https://ift.tt/2Ri9jLs

Head and Neck Diseases by Alexandros G.Sfakianakis

Αρχειοθήκη ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader

Η λίστα ιστολογίων μου

Τρίτη 2 Οκτωβρίου 2018

Durvalumab (MEDI4736) With Cetuximab in Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αρχειοθήκη ιστολογίου